Table 1.
Baseline characteristics of the CAD with T2DM and control groups.
| Variables | CAD with T2DM (n = 680) | T2DM without CAD (n = 156) | Control (n = 985) | χ2∗ | P∗ | χ2/Z† | P† |
| Male (%) | 311 (45.7) | 66 (42.3) | 360 (36.5) | 14.332 | .001 | 1.463 | <.001 |
| Age (years) | 63 (57,71) | 59 (53, 63) | 58 (53, 63) | 168.116 | <.001 | −12.697 | <.001 |
| BMI (kg/m2) | 26.0 (24.0, 28.5) | 26.2 (23.9, 28.7) | 25.0 (23.0, 27.3) | 39.816 | <.001 | −5.596 | <.001 |
| Chest pain (%) | 417 (63.9) | 66 (43.7) | 404 (41.6) | 78.86 | <.001 | 2.475 | <.001 |
| Smoking (%) | 222 (33.1) | 33 (21.2) | 244 (24.8) | 17.449 | <.001 | 1.505 | <.001 |
| Hypertension (%) | 483 (73.5) | 102 (67.1) | 445 (45.6) | 133.707 | <.001 | 3.306 | <.001 |
| Dyslipidemia (%) | 295 (45.8) | 63 (42.0) | 261 (27.0) | 63.705 | <.001 | 2.283 | <.001 |
| Ischemic stroke (%) | 100 (20.9) | 11 (7.7) | 63 (6.8) | 64.089 | <.001 | 3.598 | <.001 |
| Pulse pressure (mm Hg) | 56 (50,70) | 50 (44, 60) | 50 (40, 60) | 62.075 | <.001 | −7.68 | <.001 |
| Left atrium (cm) | 35 (32, 39) | 34 (31, 38) | 33 (30, 35) | 45.973 | <.001 | −6.723 | <.001 |
| Left ventricle end-diastolic diameter (cm) | 50 (46, 54) | 48 (46, 51) | 49 (46, 52) | 27.916 | <.001 | −5.16 | <.001 |
| Left ventricular | |||||||
| Ejection fraction (%) | 59 (54, 64) | 62 (57, 67) | 62 (58, 67) | 113.885 | <.001 | −10.213 | <.001 |
| Leukocyte (109/L) | 6.7 (5.5, 8.0) | 6.4 (5.4, 7.4) | 6.3 (5.3, 7.5) | 48.519 | <.001 | −4.598 | <.001 |
| Platelet (109/L) | 210 (170, 242) | 207 (167, 239) | 215 (181, 255) | 24.059 | <.001 | −5.295 | <.001 |
| Neutrophil (%) | 62.8 (55.7, 69.8) | 59.7 (54.5, 65.6) | 61.5 (54.2, 67.6) | 41.91 | <.001 | −2.371 | .018 |
| TC (mmol/L) | 4.31 (3.63, 5.20) | 4.22 (3.71, 5.06) | 4.24 (3.60, 4.90) | 5.468 | .065 | −8.378 | <.001 |
| HDL-C (mmol/L) | 1.0 (0.8, 1.2) | 1.07 (0.9, 1.37) | 1.1 (0.9, 1.4) | 70.846 | <.001 | −2.874 | .004 |
| LDL-C (mmol/L) | 2.34 (1.75, 3.06) | 2.13 (1.67, 2.61) | 2.33 (1.79, 2.88) | 16.803 | <.001 | −3.406 | .001 |
| Uric acid (mmol/L) | 304 (254, 369) | 291 (241, 346) | 291 (244, 343) | 11.877 | .003 | −9.898 | <.001 |
| Blood urea nitrogen (mmol/L) | 5.9 (4.8, 6.9) | 5.88 (4.83, 6.70) | 5.2 (4.3, 6.1) | 102.525 | <.001 | −4.29 | <.001 |
| Creatinine (μmol/L) | 67.2 (56.0, 80.6) | 63.2 (54.3, 75.3) | 63.5 (55.4, 72.9) | 19.489 | <.001 | 1.458 | .001 |
| Abnormal wall motion (%) | 302 (61.9) | 84 (64.1) | 432 (52.4) | 14.597 | .001 | 2.72 | <.001 |
| β-blockers (%) | 382 (57.7) | 62 (40.3) | 324 (33.4) | 95.324 | <.001 | 3.45 | <.001 |
| ACEI/ARB (%) | 328 (50.2) | 46 (30.1) | 219 (22.6) | 134.451 | <.001 | 7.314 | <.001 |
| Diuretics (%) | 152 (24.0) | 2 (1.3) | 40 (4.1) | 128.387 | <.001 | 9.007 | <.001 |
| Statin (%) | 627 (93.3) | 122 (78.2) | 594 (60.7) | 223.868 | <.001 | −19.187 | <.001 |
| TyG index | 9.42 (8.96, 9.83) | 9.46 (8.99, 10.06) | 8.72 (8.35, 9.13) | 417.848 | <.001 | −19.187 | <.001 |